drugset / Trial / NCT00709826
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will compare the anti-tumor efficacy of apricoxib and gemcitabine/erlotinib with placebo and gemcitabine/erlotinib in patients with advanced pancreatic cancer.
Timeline
- Start
- 2008-08
- Primary completion
- 2010-06
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | apricoxib | Small molecule | 400 mg | Oral |
| Background | Erlotinib | Small molecule | 100 mg | — |
| Background | Gemcitabine | Small molecule | 1000 mg/m2 | — |